Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.

Despite the PNG award termination, GeoVax anticipates a milestone-rich 2025 across its portfolio. The Company will continue to engage with government and industry partners, pursue clinical trial ...

The company intended to move the drug into late-stage testing ... Obesity treatments have become one of the more promising ...

With ambitious goals in mind, the young biotech company shows no signs of slowing down. Between making their tissue models increasingly more physiologically accurate and developing ties with drug ...